Hovione has signed a partnership agreement with Ligand to significantly ramp up the production of Captisol. Captisol, a Ligand product, is a chemically modified cyclodextrin to improve the solubility and stability of drugs. It’s used in the formulation of Gilead’s Covid-19 treatment Veklury (remdesivir). Hovione is the sole producer of this key enabling excipient. The Covid-19 pandemic has to date killed one million people; studies show that in the next 3 months cumulative deaths may m...